Loading…

The role of serum podocalyxin levels in recurrent pregnancy loss

To measure serum levels of podocalyxin (PODXL) in recurrent miscarriages as a marker of vascular endothelial dysfunction. In this case-control study, women who were hospitalized for singleton first-trimester pregnancy terminations due to missed abortion, anembryonic pregnancy, and inevitable abortio...

Full description

Saved in:
Bibliographic Details
Published in:European journal of obstetrics & gynecology and reproductive biology 2021-05, Vol.260, p.114-117
Main Authors: Yorgancı, Ayçağ, Halici Ozturk, Filiz, Hancerliogullari, Necati, Çandar, Tuba, Caglar, Ali Turhan, Ozgu-Erdinc, A. Seval
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c311t-bce5b1c582f5eb39b46a2c2d854b6f67adc14f896bb25745060cfb4210269a8c3
container_end_page 117
container_issue
container_start_page 114
container_title European journal of obstetrics & gynecology and reproductive biology
container_volume 260
creator Yorgancı, Ayçağ
Halici Ozturk, Filiz
Hancerliogullari, Necati
Çandar, Tuba
Caglar, Ali Turhan
Ozgu-Erdinc, A. Seval
description To measure serum levels of podocalyxin (PODXL) in recurrent miscarriages as a marker of vascular endothelial dysfunction. In this case-control study, women who were hospitalized for singleton first-trimester pregnancy terminations due to missed abortion, anembryonic pregnancy, and inevitable abortion were included. There were 24 patients who were admitted for the first pregnancy termination, 39 patients who were admitted for recurrent pregnancy loss (RPL), and 25 fetal cardiac activity positive patients as the control group. Demographic features, medical and obstetric histories were recorded. The measurements of serum PODXL were done by a human enzyme-linked immunosorbent assay kit. Serum PODXL levels were found to be significantly higher in the RPL group than the control group and the first time miscarriage group (13.82 [10.09−113.54] vs. 11.78 [9.25−48.80], p = 0.016 and 13.82 [10.09–113.54] vs. 11.99 [8.20–20.47], p = 0.003; respectively). Serum PODXL levels were not statistically significantly different between the first miscarriage and the control group (p = 0.62). There were positive correlation between serum PODXL levels and the number of gravida and the number of miscarriages (r = 0.217, p = 0.042, and r = 0.291, p = 0.006; respectively). Recurrent miscarriage patients had higher serum levels of PODXL than both normal pregnancies and first-time miscarriages. Our results suggest that maternal endothelial dysfunction might have a role in recurrent pregnancy losses.
doi_str_mv 10.1016/j.ejogrb.2021.03.021
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2506287679</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S030121152100141X</els_id><sourcerecordid>2506287679</sourcerecordid><originalsourceid>FETCH-LOGICAL-c311t-bce5b1c582f5eb39b46a2c2d854b6f67adc14f896bb25745060cfb4210269a8c3</originalsourceid><addsrcrecordid>eNp9kMtOwzAQRS0EoqXwBwh5ySbBj8RJNghU8ZIqsSlrK3YmJZETB7up6N_jKoUl3lwvzp0ZHYSuKYkpoeKujaG1G6diRhiNCY9DnKA5zTMWZSJNTtGccEIjRmk6QxfetyQ8zotzNOP8QGTFHD2sPwE7awDbGntwY4cHW1ldmv1302MDOzAeh58DPToH_RYPDjZ92es9Ntb7S3RWl8bD1TEX6OP5ab18jVbvL2_Lx1WkOaXbSGlIFdVpzuoUFC9UIkqmWZWniRK1yMpK06TOC6EUS7MkJYLoWiWMEiaKMtd8gW6nuYOzXyP4rewar8GYsgc7eslCheWZyIqAJhOqXTjQQS0H13Sl20tK5MGdbOXkTh7cScJliFC7OW4YVQfVX-lXVgDuJyAogV0DTnrdQK-haoKdraxs8_-GH_70gZM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2506287679</pqid></control><display><type>article</type><title>The role of serum podocalyxin levels in recurrent pregnancy loss</title><source>ScienceDirect Journals</source><creator>Yorgancı, Ayçağ ; Halici Ozturk, Filiz ; Hancerliogullari, Necati ; Çandar, Tuba ; Caglar, Ali Turhan ; Ozgu-Erdinc, A. Seval</creator><creatorcontrib>Yorgancı, Ayçağ ; Halici Ozturk, Filiz ; Hancerliogullari, Necati ; Çandar, Tuba ; Caglar, Ali Turhan ; Ozgu-Erdinc, A. Seval</creatorcontrib><description>To measure serum levels of podocalyxin (PODXL) in recurrent miscarriages as a marker of vascular endothelial dysfunction. In this case-control study, women who were hospitalized for singleton first-trimester pregnancy terminations due to missed abortion, anembryonic pregnancy, and inevitable abortion were included. There were 24 patients who were admitted for the first pregnancy termination, 39 patients who were admitted for recurrent pregnancy loss (RPL), and 25 fetal cardiac activity positive patients as the control group. Demographic features, medical and obstetric histories were recorded. The measurements of serum PODXL were done by a human enzyme-linked immunosorbent assay kit. Serum PODXL levels were found to be significantly higher in the RPL group than the control group and the first time miscarriage group (13.82 [10.09−113.54] vs. 11.78 [9.25−48.80], p = 0.016 and 13.82 [10.09–113.54] vs. 11.99 [8.20–20.47], p = 0.003; respectively). Serum PODXL levels were not statistically significantly different between the first miscarriage and the control group (p = 0.62). There were positive correlation between serum PODXL levels and the number of gravida and the number of miscarriages (r = 0.217, p = 0.042, and r = 0.291, p = 0.006; respectively). Recurrent miscarriage patients had higher serum levels of PODXL than both normal pregnancies and first-time miscarriages. Our results suggest that maternal endothelial dysfunction might have a role in recurrent pregnancy losses.</description><identifier>ISSN: 0301-2115</identifier><identifier>EISSN: 1872-7654</identifier><identifier>DOI: 10.1016/j.ejogrb.2021.03.021</identifier><identifier>PMID: 33765479</identifier><language>eng</language><publisher>Ireland: Elsevier B.V</publisher><subject>Abortion, Habitual ; Abortion, Induced ; Case-Control Studies ; Endothelial dysfunction ; Female ; Humans ; Miscarriage ; Podocalyxin ; Pregnancy ; Recurrent pregnancy loss ; Sialoglycoproteins</subject><ispartof>European journal of obstetrics &amp; gynecology and reproductive biology, 2021-05, Vol.260, p.114-117</ispartof><rights>2021 Elsevier B.V.</rights><rights>Copyright © 2021 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c311t-bce5b1c582f5eb39b46a2c2d854b6f67adc14f896bb25745060cfb4210269a8c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33765479$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yorgancı, Ayçağ</creatorcontrib><creatorcontrib>Halici Ozturk, Filiz</creatorcontrib><creatorcontrib>Hancerliogullari, Necati</creatorcontrib><creatorcontrib>Çandar, Tuba</creatorcontrib><creatorcontrib>Caglar, Ali Turhan</creatorcontrib><creatorcontrib>Ozgu-Erdinc, A. Seval</creatorcontrib><title>The role of serum podocalyxin levels in recurrent pregnancy loss</title><title>European journal of obstetrics &amp; gynecology and reproductive biology</title><addtitle>Eur J Obstet Gynecol Reprod Biol</addtitle><description>To measure serum levels of podocalyxin (PODXL) in recurrent miscarriages as a marker of vascular endothelial dysfunction. In this case-control study, women who were hospitalized for singleton first-trimester pregnancy terminations due to missed abortion, anembryonic pregnancy, and inevitable abortion were included. There were 24 patients who were admitted for the first pregnancy termination, 39 patients who were admitted for recurrent pregnancy loss (RPL), and 25 fetal cardiac activity positive patients as the control group. Demographic features, medical and obstetric histories were recorded. The measurements of serum PODXL were done by a human enzyme-linked immunosorbent assay kit. Serum PODXL levels were found to be significantly higher in the RPL group than the control group and the first time miscarriage group (13.82 [10.09−113.54] vs. 11.78 [9.25−48.80], p = 0.016 and 13.82 [10.09–113.54] vs. 11.99 [8.20–20.47], p = 0.003; respectively). Serum PODXL levels were not statistically significantly different between the first miscarriage and the control group (p = 0.62). There were positive correlation between serum PODXL levels and the number of gravida and the number of miscarriages (r = 0.217, p = 0.042, and r = 0.291, p = 0.006; respectively). Recurrent miscarriage patients had higher serum levels of PODXL than both normal pregnancies and first-time miscarriages. Our results suggest that maternal endothelial dysfunction might have a role in recurrent pregnancy losses.</description><subject>Abortion, Habitual</subject><subject>Abortion, Induced</subject><subject>Case-Control Studies</subject><subject>Endothelial dysfunction</subject><subject>Female</subject><subject>Humans</subject><subject>Miscarriage</subject><subject>Podocalyxin</subject><subject>Pregnancy</subject><subject>Recurrent pregnancy loss</subject><subject>Sialoglycoproteins</subject><issn>0301-2115</issn><issn>1872-7654</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kMtOwzAQRS0EoqXwBwh5ySbBj8RJNghU8ZIqsSlrK3YmJZETB7up6N_jKoUl3lwvzp0ZHYSuKYkpoeKujaG1G6diRhiNCY9DnKA5zTMWZSJNTtGccEIjRmk6QxfetyQ8zotzNOP8QGTFHD2sPwE7awDbGntwY4cHW1ldmv1302MDOzAeh58DPToH_RYPDjZ92es9Ntb7S3RWl8bD1TEX6OP5ab18jVbvL2_Lx1WkOaXbSGlIFdVpzuoUFC9UIkqmWZWniRK1yMpK06TOC6EUS7MkJYLoWiWMEiaKMtd8gW6nuYOzXyP4rewar8GYsgc7eslCheWZyIqAJhOqXTjQQS0H13Sl20tK5MGdbOXkTh7cScJliFC7OW4YVQfVX-lXVgDuJyAogV0DTnrdQK-haoKdraxs8_-GH_70gZM</recordid><startdate>202105</startdate><enddate>202105</enddate><creator>Yorgancı, Ayçağ</creator><creator>Halici Ozturk, Filiz</creator><creator>Hancerliogullari, Necati</creator><creator>Çandar, Tuba</creator><creator>Caglar, Ali Turhan</creator><creator>Ozgu-Erdinc, A. Seval</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202105</creationdate><title>The role of serum podocalyxin levels in recurrent pregnancy loss</title><author>Yorgancı, Ayçağ ; Halici Ozturk, Filiz ; Hancerliogullari, Necati ; Çandar, Tuba ; Caglar, Ali Turhan ; Ozgu-Erdinc, A. Seval</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c311t-bce5b1c582f5eb39b46a2c2d854b6f67adc14f896bb25745060cfb4210269a8c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Abortion, Habitual</topic><topic>Abortion, Induced</topic><topic>Case-Control Studies</topic><topic>Endothelial dysfunction</topic><topic>Female</topic><topic>Humans</topic><topic>Miscarriage</topic><topic>Podocalyxin</topic><topic>Pregnancy</topic><topic>Recurrent pregnancy loss</topic><topic>Sialoglycoproteins</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yorgancı, Ayçağ</creatorcontrib><creatorcontrib>Halici Ozturk, Filiz</creatorcontrib><creatorcontrib>Hancerliogullari, Necati</creatorcontrib><creatorcontrib>Çandar, Tuba</creatorcontrib><creatorcontrib>Caglar, Ali Turhan</creatorcontrib><creatorcontrib>Ozgu-Erdinc, A. Seval</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of obstetrics &amp; gynecology and reproductive biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yorgancı, Ayçağ</au><au>Halici Ozturk, Filiz</au><au>Hancerliogullari, Necati</au><au>Çandar, Tuba</au><au>Caglar, Ali Turhan</au><au>Ozgu-Erdinc, A. Seval</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The role of serum podocalyxin levels in recurrent pregnancy loss</atitle><jtitle>European journal of obstetrics &amp; gynecology and reproductive biology</jtitle><addtitle>Eur J Obstet Gynecol Reprod Biol</addtitle><date>2021-05</date><risdate>2021</risdate><volume>260</volume><spage>114</spage><epage>117</epage><pages>114-117</pages><issn>0301-2115</issn><eissn>1872-7654</eissn><abstract>To measure serum levels of podocalyxin (PODXL) in recurrent miscarriages as a marker of vascular endothelial dysfunction. In this case-control study, women who were hospitalized for singleton first-trimester pregnancy terminations due to missed abortion, anembryonic pregnancy, and inevitable abortion were included. There were 24 patients who were admitted for the first pregnancy termination, 39 patients who were admitted for recurrent pregnancy loss (RPL), and 25 fetal cardiac activity positive patients as the control group. Demographic features, medical and obstetric histories were recorded. The measurements of serum PODXL were done by a human enzyme-linked immunosorbent assay kit. Serum PODXL levels were found to be significantly higher in the RPL group than the control group and the first time miscarriage group (13.82 [10.09−113.54] vs. 11.78 [9.25−48.80], p = 0.016 and 13.82 [10.09–113.54] vs. 11.99 [8.20–20.47], p = 0.003; respectively). Serum PODXL levels were not statistically significantly different between the first miscarriage and the control group (p = 0.62). There were positive correlation between serum PODXL levels and the number of gravida and the number of miscarriages (r = 0.217, p = 0.042, and r = 0.291, p = 0.006; respectively). Recurrent miscarriage patients had higher serum levels of PODXL than both normal pregnancies and first-time miscarriages. Our results suggest that maternal endothelial dysfunction might have a role in recurrent pregnancy losses.</abstract><cop>Ireland</cop><pub>Elsevier B.V</pub><pmid>33765479</pmid><doi>10.1016/j.ejogrb.2021.03.021</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0301-2115
ispartof European journal of obstetrics & gynecology and reproductive biology, 2021-05, Vol.260, p.114-117
issn 0301-2115
1872-7654
language eng
recordid cdi_proquest_miscellaneous_2506287679
source ScienceDirect Journals
subjects Abortion, Habitual
Abortion, Induced
Case-Control Studies
Endothelial dysfunction
Female
Humans
Miscarriage
Podocalyxin
Pregnancy
Recurrent pregnancy loss
Sialoglycoproteins
title The role of serum podocalyxin levels in recurrent pregnancy loss
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T21%3A48%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20role%20of%20serum%20podocalyxin%20levels%20in%20recurrent%20pregnancy%20loss&rft.jtitle=European%20journal%20of%20obstetrics%20&%20gynecology%20and%20reproductive%20biology&rft.au=Yorganc%C4%B1,%20Ay%C3%A7a%C4%9F&rft.date=2021-05&rft.volume=260&rft.spage=114&rft.epage=117&rft.pages=114-117&rft.issn=0301-2115&rft.eissn=1872-7654&rft_id=info:doi/10.1016/j.ejogrb.2021.03.021&rft_dat=%3Cproquest_cross%3E2506287679%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c311t-bce5b1c582f5eb39b46a2c2d854b6f67adc14f896bb25745060cfb4210269a8c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2506287679&rft_id=info:pmid/33765479&rfr_iscdi=true